NEU 0.98% $15.12 neuren pharmaceuticals limited

NEU posted a great quarterly, yet ASX is still not rewarding it...

  1. 284 Posts.
    lightbulb Created with Sketch. 53
    NEU posted a great quarterly, yet ASX is still not rewarding it properly. The lack of broader understanding of this stock amongst institutional investors in Australia is astounding. If NEU was listed in the US it would be highly rated. Petra's analyst noted RETA's takeover last week in today's NEU update. It gives a comparison between NEU and RETA. RETA for reference is being taken over at US$7.3bn or A$10bn+. Quite astronomical valuation differences.

    https://hotcopper.com.au/data/attachments/5469/5469591-fd42b2fe5fa0fdabb4942fc21850e05b.jpg
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.